Clinical trial
Multicenter Performance Study of QuadQuik Invitro Diagnostic Device
NCT05692505 is registered in ClinicalTrials.gov with Genlantis Diagnostics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Performance Study of QuadQuik Invitro Diagnostic Device
- Lead sponsor
- Genlantis Diagnostics
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 1, 2023
- Completion date
- June 1, 2023
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis b, hepatitis c, hiv infections, syphilis infection